2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one

C19H24ClN7O3 — CID 155883529

IUPAC2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one
SMILESCC1CNN2NC(N)N(Cc3nc([C@@H]4CO[C@@H](c5ccc(Cl)cc5)C4)no3)C(=O)C12
InChIInChI=1S/C19H24ClN7O3/c1-10-7-22-27-16(10)18(28)26(19(21)24-27)8-15-23-17(25-30-15)12-6-14(29-9-12)11-2-4-13(20)5-3-11/h2-5,10,12,14,16,19,22,24H,6-9,21H2,1H3/t10?,12-,14+,16?,19?/m0/s1
InChIKeyVBRXRZSZBBNENG-TYHWYKFUSA-N
MW433.90 g/mol
LogP0.88
Rot. Bonds4

About 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one

2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one (PubChem CID 155883529) has the molecular formula C19H24ClN7O3 and a molecular weight of 433.90 g/mol. Its IUPAC name is 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one.

Molecular Properties

Compound Name2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one
PubChem CID155883529
Molecular FormulaC19H24ClN7O3
Molecular Weight433.90 g/mol
Exact Mass433.16
IUPAC Name2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one
SMILESCC1CNN2NC(N)N(Cc3nc([C@@H]4CO[C@@H](c5ccc(Cl)cc5)C4)no3)C(=O)C12
InChIInChI=1S/C19H24ClN7O3/c1-10-7-22-27-16(10)18(28)26(19(21)24-27)8-15-23-17(25-30-15)12-6-14(29-9-12)11-2-4-13(20)5-3-11/h2-5,10,12,14,16,19,22,24H,6-9,21H2,1H3/t10?,12-,14+,16?,19?/m0/s1
InChIKeyVBRXRZSZBBNENG-TYHWYKFUSA-N
XLogP0.88
TPSA121.78 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500433.90
LogP ≤ 50.88
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US10710994, Example 83
CID 139494963
US10710994, Example 3
CID 155883528
US10710994, Example 66
CID 155883535
US10710994, Example 127
CID 155883556
US10710994, Example 143
CID 155883560
US10710994, Example 145
CID 155883561
US10710994, Example 48
CID 155883531
US10710994, Example 73
CID 139486483
US10710994, Example 111
CID 139486488
US10710994, Example 128
CID 139486552
US10710994, Example 100
CID 139486634
US10710994, Example 108
CID 139495072

Frequently Asked Questions

What is the IUPAC name of 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one?
The IUPAC name of 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one (CID 155883529) is 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one.
What is the SMILES notation for 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one?
The canonical SMILES for 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one is CC1CNN2NC(N)N(Cc3nc([C@@H]4CO[C@@H](c5ccc(Cl)cc5)C4)no3)C(=O)C12.
What is the InChIKey of 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one?
The InChIKey is VBRXRZSZBBNENG-TYHWYKFUSA-N. The full InChI is InChI=1S/C19H24ClN7O3/c1-10-7-22-27-16(10)18(28)26(19(21)24-27)8-15-23-17(25-30-15)12-6-14(29-9-12)11-2-4-13(20)5-3-11/h2-5,10,12,14,16,19,22,24H,6-9,21H2,1H3/t10?,12-,14+,16?,19?/m0/s1.
What are the key properties of 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one?
2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one has a molecular weight of 433.90 g/mol, XLogP of 0.88, 4 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-3-[[3-[(3R,5R)-5-(4-chlorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-5-methyl-1,2,4a,5,6,7-hexahydropyrazolo[5,1-f][1,2,4]triazin-4-one is sourced from PubChem (CID 155883529), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).